CTOs on the Move

Brown Physicians

www.brownphysicians.org

 
Brown Physicians, Incorporated (BPI) is a community-based not-for-profit multi-specialty practice group founded and led by faculty affiliated with The Warren Alpert Medical School of Brown University. Our mission is to provide outstanding patient care, exceptional medical education, and groundbreaking advances in research to promote better health for the people of Rhode Island and its surrounding communities. BPI is composed of six foundations, which include Brown Dermatology, Brown Emergency Medicine, Brown Medicine, Brown Neurology, Brown Urology, and University Surgical Associates.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Hoosick Falls Health Center

Hoosick Falls Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Hoosick Falls, NY. To find more information about Hoosick Falls Health Center, please visit www.hfhc.org

Health Care Financing Administration

Health Care Financing Administration is a Gwynn Oak, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Atlas Senior Living

A premier senior housing company through ownership and third party management that focuses on maximizing revenue drivers and operational efficiencies by allowing individual resident needs and preferences to drive service offerings and by focusing on resident and employee satisfaction.

Athena Health Care Systems

Athena Health Care Systems is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Athena Health Care Systems is based in Farmington, CT. You can find more information on Athena Health Care Systems at www.athenahealthcare.com

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.